Myocardial structure and function in patients with metabolic syndrome - Echocardiographic and ergospirometric assessment;Zespół metaboliczny a budowa i funkcja mieśnia sercowego - Ocena echokardiograficzna i ergospirometryczna

Polski Merkuriusz Lekarski

Volumn 25, Issue 145, 2008, Pages 15-18

  Janiszewski, Maciej ^a,b   Cudnoch Jedrzejewska, Agnieszka ^a   Sadkowska, Katarzyna ^a   Mamcarz, Artur ^a   Braksator, Wojciech ^a   Puchalska, Liana ^a   Graczak, Izabella ^a   Światowiec, Andrzej ^a   Kuch, Marek ^a   Dłuzniewski, Mirosław ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b WARSZAWSKI UNIWERSYTET MEDYCZNY   (Poland)

Author keywords

Diastolic function; E A ratio; Ergospirometry; Metabolic syndrome

Indexed keywords

ARTICLE; DIASTOLE; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HUMAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OXYGEN CONSUMPTION; PATHOLOGY; SPIROMETRY;

DIASTOLE; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART FAILURE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MYOCARDIUM; OXYGEN CONSUMPTION; SPIROMETRY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 49949110959     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Chinali M., Devereux R.B., Howard B.V. i wsp.: Comparison of cardiac structure and function in American Indian with and without the metabolic syndrome (the Strong Heart Study). Am. J. Cardiol., 2004, 93 (1), 40-44.
2. Ford E.S., Giles W.H., Dietz W.H.: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA, 2002, 287(3), 356-359.
3. Ford E.S., Giles W.H., Mokdad A.H.: Increasing Prevalence of the Metabolic Syndrome Among U.S. Adults. Diab. Care, 2004, 27, 2444-2449.
4. Grandi A.M., Maresca A.M., Giudici E. i wsp.: Metabolic syndrome and morphofunctional characteristics of the left ventricle in clinically hypertensive nondiabetic subjects. Am. J. Hypertens., 2006, 19(2), 199-205.
5. Ingelsson E., Arnlov J., Lind L. i wsp.: The metabolic syndrome and risk for heart failure in middle-aged men. Heart, 2006, 92(10), 1409-1413.
6. Lind L., Andersson P.E., Andren B. i wsp.: Left ventricular hypertrophy in hypertension is associated with the insulin resistance metabolic syndrome. J. Hypertens., 1995, 13(4), 433-438.
7. Mamcarz A., Braksator W., Światowiec A. i wsp.: Zaburzenia funkcji skurczowej i rozkurczowej lewej komory u chorych z cukrzyca i niemym niedokrwieniem. Pol. Przegl. Kardiolog., 2003, 5, 25-32.
8. McNeill A.M., Rosamond W.D., Girman C.J. i wsp.: The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diab. Care, 2005, 28(2), 385-390.
9. Mule G., Cottone S., Nardi E. i wsp.: Metabolic syndrome in subjects with essential hypertension: relationships with subclinical cardiovascular and renal damage. Minerva Cardioangiol., 2006, 54(2), 173-194.
10. Pasierski T., Narkiewicz K.: Przerost lewej komory i niewydolność serca. W: Diabetokardiologia. Med. Prakt., Kraków, 2004, 75-83.
11. Swedberg K., Cleland J., Dargie H. i wsp.: Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur. Heart J., 2005, 26 (11), 1115-1140.
12. Szczech R., Chrastowska M., Sakiewicz W. i wsp.: Inhibitory konwertazy angiotensyny w leczeniu zespołu metabolicznego. W: Inhibitory konwertazy angiotensyny w leczeniu chorób układu sercowo-naczyniowego. Red. Januszewicz A., Januszewicz W., Rużył ło W. Med. Prakt., Kraków, 2005, 125-138.
13. Watts G.F., Warwick T.H.: Ventricular dysfunction in early diabetic heart disease: detection, mechanisms and significance. Clin. Sci. (Lond)., 2003, 105(5), 537-540.
14. Wilson P.W., D'Agostino R.B., Parsie H. i wsp.: Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation, 2005, 112(20), 3066-3072.
15. Wong C.Y., O'Moore-Sullivan T., Fang Z.V. i wsp.: Myocardial and vascular dysfunction and exercise capacity in the metabolic syndrome. Am. J. Cardiol., 2005, 96(12), 1686-1691.
16. Wyrzykowski B., Bandosz P., Zdrojewski T.: Ocena czestości wystepowania zespołu metabolicznego w Polsce. Kardioprofil., 2006, 4, 3-11.